| Shorepoint Obstetrics And Gynecology- Rhc | |
|
1012 N Mills Ave Arcadia FL 34266-8811 | |
| (941) 766-0400 | |
| Not Available |
| Full Name | Shorepoint Obstetrics And Gynecology- Rhc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1012 N Mills Ave, Arcadia, Florida |
| Authorized Official Name and Position | Jennifer L Jackson (SR DIRECTOR PROVIDER ENROLLMENT) |
| Authorized Official Contact | 6154653334 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Shorepoint Obstetrics And Gynecology- Rhc Po Box 689022 Franklin TN 37068-9022 Ph: () - | Shorepoint Obstetrics And Gynecology- Rhc 1012 N Mills Ave Arcadia FL 34266-8811 Ph: (941) 766-0400 |
| NPI Number | 1730672379 |
|---|---|
| Provider Enumeration Date | 06/08/2018 |
| Last Update Date | 03/18/2022 |
| Medicare PECOS PAC ID | 8729187901 |
|---|---|
| Medicare Enrollment ID | O20180813000071 |
News Archive
Poisoning is now the second leading cause of unintentional injury death in the U.S. While several recent high-profile Hollywood celebrity cases have brought the problem to public attention, the rates of unintentional poisoning deaths have been on the rise for more than 15 years.
Female mice exhibit a strong drive to socialize with other females following periods of acute isolation, significantly increasing their production of social calls that are akin to human emotional vocalizations, new Cornell University research finds.
ARIAD Pharmaceuticals, Inc., today announced top-line data showing that ridaforolimus, an investigational oral mTOR inhibitor, met the primary endpoint of improved progression-free survival (PFS) compared to placebo in the Phase 3 SUCCEED trial conducted in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.
Celsis In Vitro, Inc. announced today that it has filed a patent infringement lawsuit against Invitrogen Corporation and CellzDirect, Inc. in the United States District Court for the Northern District of Illinois in Chicago and has moved for a preliminary injunction. Invitrogen, the parent of CellzDirect, is itself a wholly-owned subsidiary of Life Technologies of Carlsbad, California.
Scientists at the Hotchkiss Brain Institute, Alberta Children's Hospital Research Institute, and Owerko Centre at UCalgary's Cumming School of Medicine have made a breakthrough discovery that could lead to treatment of Fragile X syndrome, the leading genetic cause of Autism Spectrum Disorder.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730672379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Poisoning is now the second leading cause of unintentional injury death in the U.S. While several recent high-profile Hollywood celebrity cases have brought the problem to public attention, the rates of unintentional poisoning deaths have been on the rise for more than 15 years.
Female mice exhibit a strong drive to socialize with other females following periods of acute isolation, significantly increasing their production of social calls that are akin to human emotional vocalizations, new Cornell University research finds.
ARIAD Pharmaceuticals, Inc., today announced top-line data showing that ridaforolimus, an investigational oral mTOR inhibitor, met the primary endpoint of improved progression-free survival (PFS) compared to placebo in the Phase 3 SUCCEED trial conducted in patients with metastatic soft-tissue or bone sarcomas who previously had a favorable response to chemotherapy.
Celsis In Vitro, Inc. announced today that it has filed a patent infringement lawsuit against Invitrogen Corporation and CellzDirect, Inc. in the United States District Court for the Northern District of Illinois in Chicago and has moved for a preliminary injunction. Invitrogen, the parent of CellzDirect, is itself a wholly-owned subsidiary of Life Technologies of Carlsbad, California.
Scientists at the Hotchkiss Brain Institute, Alberta Children's Hospital Research Institute, and Owerko Centre at UCalgary's Cumming School of Medicine have made a breakthrough discovery that could lead to treatment of Fragile X syndrome, the leading genetic cause of Autism Spectrum Disorder.
› Verified 4 days ago
Family Care Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 819 N Mills Ave, Arcadia, FL 34266 Phone: 863-491-2277 Fax: 863-491-3077 | |
Arcadia Int Medicine P A Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 830 N Mills Ave, Arcadia, FL 34266 Phone: 863-494-6599 Fax: 863-494-5467 | |
Community Care Family Healthcare Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1148 E Gibson St, Build C, Arcadia, FL 34266 Phone: 863-494-6222 Fax: 863-494-3227 | |
Twin Rivers Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 888 N Robert Ave, Arcadia, FL 34266 Phone: 863-494-8401 Fax: 863-993-7622 | |
Catalyst Walk-in Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1707 East Oak Street, Arcadia, FL 34266 Phone: 863-448-9242 Fax: 863-491-0760 | |
Family Care Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 819 N Mills Ave, Arcadia, FL 34266 Phone: 863-491-2277 Fax: 863-491-3077 | |
Ama Arcadia Pharmacy Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 425 Nursing Home Dr, Arcadia, FL 34266 Phone: 863-993-2966 Fax: 863-494-5491 |